Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:51:32.691Z.
Calculation as of: 2026-10-06T15:51:32.691Z.
Quote observation: 2026-10-06T15:50:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e02887d9f7d553dead588493e3d1cc1cda6164751857f77264c258b40fe63259
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-07-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$283.42M
EV/FCF Ratio
N/A
TTM Avg
1.69x
3Y Avg
1.69x
5Y Avg
1.69x
Market Cap
$288.87M
EV/FCF Ratio
N/A
TTM Avg
37.98x
3Y Avg
37.98x
5Y Avg
37.98x
Market Cap
$290.91M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$276.26M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$269.13M
EV/FCF Ratio
N/A
TTM Avg
48.59x
3Y Avg
48.59x
5Y Avg
48.59x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | $283.92M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $283.42M | N/A | 1.69x | 1.69x | 1.69x |
| Aurora Cannabis Inc. (ACB)vs › | $280.60M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.87M | N/A | 37.98x | 37.98x | 37.98x |
| Fate Therapeutics, Inc. (FATE)vs › | $279.16M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.91M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $290.74M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $276.26M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $269.13M | N/A | 48.59x | 48.59x | 48.59x |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2025-07-29 | 58.23x |
| 2025-07-28 | 60.05x |
| 2025-07-25 | 60.05x |
| 2025-07-24 | 60.13x |
| 2025-07-23 | 60.87x |
| 2025-07-22 | 53.76x |
| 2025-07-21 | 54.18x |
| 2025-07-18 | 58.72x |
| 2025-07-17 | 61.12x |
| 2025-07-16 | 60.62x |
| 2025-07-15 | 60.29x |
| 2025-07-14 | 60.79x |
| 2025-07-11 | 60.21x |
| 2025-07-10 | 61.70x |
| 2025-07-09 | 60.87x |
| 2025-07-08 | 60.38x |
| 2025-07-07 | 53.52x |
| 2025-07-03 | 52.69x |
| 2025-07-02 | 52.77x |
| 2025-07-01 | 52.03x |
| 2025-06-30 | 52.36x |
| 2025-06-27 | 54.18x |
| 2025-06-26 | 56.49x |
| 2025-06-25 | 54.67x |
| 2025-06-24 | 54.92x |
| 2025-06-23 | 54.76x |
| 2025-06-20 | 53.35x |
| 2025-06-18 | 48.06x |
| 2025-06-17 | 48.64x |
| 2025-06-16 | 51.70x |
| 2025-06-13 | 52.11x |
| 2025-06-12 | 51.53x |
| 2025-06-11 | 51.95x |
| 2025-06-10 | 52.52x |
| 2025-06-09 | 54.34x |
| 2025-06-06 | 55.42x |
| 2025-06-05 | 54.26x |
| 2025-06-04 | 53.60x |
| 2025-06-03 | 53.68x |
| 2025-06-02 | 53.02x |
| 2025-05-30 | 52.36x |
| 2025-05-29 | 53.93x |
| 2025-05-28 | 52.52x |
| 2025-05-27 | 47.98x |
| 2025-05-23 | 48.72x |
| 2025-05-22 | 46.08x |
| 2025-05-21 | 47.15x |
| 2025-05-20 | 49.30x |
| 2025-05-19 | 52.77x |
| 2025-05-16 | 52.36x |
| 2025-05-15 | 50.04x |
| 2025-05-14 | 42.03x |
| 2025-05-13 | 43.35x |
| 2025-05-12 | 42.44x |
| 2025-05-09 | 39.88x |
| 2025-05-08 | 40.21x |
| 2025-05-07 | 37.40x |
| 2025-05-06 | 39.71x |
| 2025-05-05 | 42.85x |
| 2025-05-02 | 41.94x |
